Literature DB >> 25207580

Influence of patient's physiologic factors and immobilization choice with stereotactic body radiotherapy for upper lung tumors.

Terence T Sio1, Andrew R Jensen, Robert C Miller, Luis E Fong de los Santos, Christopher L Hallemeier, Nathan R Foster, Sean S Park, Heather J Bauer, Kenneth Chang, Yolanda I Garces, Kenneth R Olivier.   

Abstract

The purpose of the present study was to compare the impact of pulmonary function, body habitus, and stereotactic body radiation therapy (SBRT) immobilization on setup and reproducibility for upper lung tumor. From 2008 through 2011, our institution's prospective SBRT database was searched for patients with upper lung tumors. Two SBRT immobilization strategies were used: full-length BodyFIX and thermoplastic S-frame. At simulation, free-breathing, four-dimensional computed tomography was performed. For each treatment, patients were set up to isocenter with in-room lasers and skin tattoos. Shifts from initial and subsequent couch positions with cone-beam computed tomography (CBCT) were analyzed. Accounting for setup uncertainties, institutional tolerance of CBCT-based shifts for treatment was 2, 2, and 4 mm in left-right, anterior-posterior, and cranial-caudal directions, respectively; shifts exceeding these limits required reimaging. Each patient's pretreatment pulmonary function test was recorded. A multistep, multivariate linear regression model was performed to elucidate intervariable dependency for three-dimensional calculated couch shift parameters. BodyFIX was applied to 76 tumors and S-frame to 17 tumors. Of these tumors, 41 were non-small cell lung cancer and 15 were metastatic from other sites. Lesions measured < 1 (15%), 1.1 to 2 (50%), 2.1 to 3 (25%), and > 3 (11%) cm. Errors from first shifts of first fractions were significantly less with S-frame than BodyFIX (p < 0.001). No difference in local control (LC) was found between S-frame and BodyFIX (p = 0.35); two-year LC rate was 94%. Multivariate modeling confirmed that the ratio of forced expiratory volume in the first second of expiration to forced vital capacity, body habitus, and the immobilization device significantly impacted couch shift errors. For upper lung tumors, initial setup was more consistent with S-frame than BodyFIX, resulting in fewer CBCT scans. Patients with obese habitus and poor lung function had more SBRT setup uncertainty; however, outcome and probability for LC remained excellent.

Entities:  

Mesh:

Year:  2014        PMID: 25207580      PMCID: PMC5711083          DOI: 10.1120/jacmp.v15i5.4931

Source DB:  PubMed          Journal:  J Appl Clin Med Phys        ISSN: 1526-9914            Impact factor:   2.102


Supplementary Material Click here for additional data file.
  19 in total

1.  Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors:  Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

2.  Reassessment of declines in pulmonary function ≥1 year after stereotactic body radiotherapy.

Authors:  Atsuya Takeda; Tatsuji Enomoto; Naoko Sanuki; Hiroshi Handa; Yousuke Aoki; Yohei Oku; Etsuo Kunieda
Journal:  Chest       Date:  2013-01       Impact factor: 9.410

Review 3.  Preoperative evaluation of the lung resection candidate.

Authors:  Peter Mazzone
Journal:  Cleve Clin J Med       Date:  2012-05       Impact factor: 2.321

4.  Stereotactic body radiation therapy for lung metastases.

Authors:  Umberto Ricardi; Andrea Riccardo Filippi; Alessia Guarneri; Riccardo Ragona; Cristina Mantovani; Francesca Giglioli; Angela Botticella; Patrizia Ciammella; Cristina Iftode; Lucio Buffoni; Enrico Ruffini; Giorgio Vittorio Scagliotti
Journal:  Lung Cancer       Date:  2011-07-02       Impact factor: 5.705

5.  A comparison of two immobilization systems for stereotactic body radiation therapy of lung tumors.

Authors:  Kathy Han; Patrick Cheung; Parminder S Basran; Ian Poon; Latifa Yeung; Fiona Lochray
Journal:  Radiother Oncol       Date:  2010-02-26       Impact factor: 6.280

6.  Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.

Authors:  Yasushi Nagata; Kenji Takayama; Yukinori Matsuo; Yoshiki Norihisa; Takashi Mizowaki; Takashi Sakamoto; Masato Sakamoto; Michihide Mitsumori; Keiko Shibuya; Norio Araki; Shinsuke Yano; Masahiro Hiraoka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-19       Impact factor: 7.038

7.  Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients.

Authors:  Joern Wulf; Ulrich Haedinger; Ulrich Oppitz; Wibke Thiele; Gerd Mueller; Michael Flentje
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-09-01       Impact factor: 7.038

8.  Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases.

Authors:  Peter Fritz; Hans-Jörg Kraus; Werner Mühlnickel; Udo Hammer; Wolfram Dölken; Walburga Engel-Riedel; Assad Chemaissani; Erich Stoelben
Journal:  Radiat Oncol       Date:  2006-08-20       Impact factor: 3.481

9.  Vinflunine -- an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study.

Authors:  J Bennouna; J-L Breton; J-M Tourani; C Ottensmeier; M O'Brien; P Kosmidis; T E Huat; M-C Pinel; C Colin; J-Y Douillard
Journal:  Br J Cancer       Date:  2006-05-22       Impact factor: 7.640

10.  Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results.

Authors:  Fumiya Baba; Yuta Shibamoto; Natsuo Tomita; Chisa Ikeya-Hashizume; Kyota Oda; Shiho Ayakawa; Hiroyuki Ogino; Chikao Sugie
Journal:  Radiat Oncol       Date:  2009-05-28       Impact factor: 3.481

View more
  4 in total

1.  Choice of immobilization of stereotactic body radiotherapy in lung tumor patient by BMI.

Authors:  Guofu Chen; Baiqiang Dong; Guoping Shan; Xiuqin Zhang; Huarong Tang; Yuchen Li; Zhenhua Wang; Wei Xu; Gang Xu; Guiming Yan; Feiyan Zhang; Xiao Hu; Jun Yang; Yujin Xu; Ming Chen; Jin Wang
Journal:  BMC Cancer       Date:  2019-06-14       Impact factor: 4.430

Review 2.  Special stereotactic radiotherapy techniques: procedures and equipment for treatment simulation and dose delivery.

Authors:  Lisa Paoletti; Corrado Ceccarelli; Claudia Menichelli; Cynthia Aristei; Simona Borghesi; Enrico Tucci; Paolo Bastiani; Salvatore Cozzi
Journal:  Rep Pract Oncol Radiother       Date:  2022-03-22

3.  To gate or not to gate - dosimetric evaluation comparing Gated vs. ITV-based methodologies in stereotactic ablative body radiotherapy (SABR) treatment of lung cancer.

Authors:  Joshua Kim; Qixue Wu; Bo Zhao; Ning Wen; Munther Ajlouni; Benjamin Movsas; Indrin J Chetty
Journal:  Radiat Oncol       Date:  2016-09-22       Impact factor: 3.481

4.  Evaluation of the tumor movement and the reproducibility of two different immobilization setups for image-guided stereotactic body radiotherapy of liver tumors.

Authors:  Constantin Dreher; Markus Oechsner; Michael Mayinger; Stefanie Beierl; Marciana-Nona Duma; Stephanie E Combs; Daniel Habermehl
Journal:  Radiat Oncol       Date:  2018-01-30       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.